[Image from Medtronic] A Minnesota judge has dismissed a class action lawsuit alleging securities fraud related to insulin pumps made by Medtronic (NYSE:MDT). Laura M. Provinzino, U.S. District Judge ...

Medtronic PLC investors again failed to adequately allege the device maker’s statements about its MiniMed insulin pumps constituted securities fraud, a federal court said. The latest version of the ...

SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that its t:slim X2™ insulin pump with Control-IQ+ ...

Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that its t:slim X2™ insulin pump with Control-IQ+ automated insulin delivery (AID ...

Medtronic has received an expanded label from the Food and Drug Administration to pair its MiniMed 780G insulin pump with a glucose sensor being developed by Abbott for Medtronic. Medtronic and Abbott ...

Medtronic has obtained a pair of major green lights from the FDA for its flagship insulin pump—opening up the MiniMed 780G to adults with Type 2 diabetes in the U.S. and allowing it to connect with a ...

The U.S. Food & Drug Administration has issued an urgent medical device correction. Specifically, an error on the t:slim X2 insulin pump has been stopping insulin ...

The U.S. Food & Drug Administration has issued an urgent medical device correction for certain insulin pumps manufactured by Tandem Diabetes Care after 700 incidents ...

The U.S. Food & Drug Administration has issued an urgent medical device correction. Specifically, an error on the t:slim X2 insulin pump has been stopping insulin ...

A medical device manufacturer has issued an urgent correction for select insulin pumps due to a possible error that could result in insulin not being delivered, the U ...

Aug 7 (Reuters) - Tandem Diabetes Care (TNDM.O), opens new tab issued a voluntary correction for an insulin pump model due to a speaker malfunction that disrupts communication with glucose monitoring ...